• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin J Am Soc Nephrol . Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study

tetano

Editor, Senior Moderator
Clin J Am Soc Nephrol


. 2021 Feb 23;CJN.09130620.
doi: 10.2215/CJN.09130620. Online ahead of print.
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study


Alexandre Karras[SUP] 1 2 [/SUP], Marine Livrozet[SUP] 2 3 [/SUP], H?l?ne Lazareth[SUP] 4 2 [/SUP], Nicolas Benichou[SUP] 4 2 [/SUP], Jean-S?bastien Hulot[SUP] 2 3 [/SUP], Antoine Fayol[SUP] 2 3 [/SUP], Sophie Chauvet[SUP] 4 2 [/SUP], Anne-Sophie Jannot[SUP] 2 5 [/SUP], Marie-Aude Penet[SUP] 2 6 [/SUP], Jean-Luc Diehl[SUP] 2 7 [/SUP], Anne Godier[SUP] 2 8 [/SUP], Olivier Sanchez[SUP] 2 9 [/SUP], Tristan Mirault[SUP] 2 10 [/SUP], Eric Thervet[SUP] 4 2 [/SUP], Nicolas Pallet[SUP] 2 11 [/SUP]



Affiliations

Abstract

Background and objectives: Kidney involvement is frequent among patients with coronavirus disease 2019 (COVID-19), and occurrence of AKI is associated with higher mortality in this population. The objective of this study was to describe occurrence and significance of proteinuria in this setting. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS : We conducted a single-center retrospective study to describe the characteristic features of proteinuria measured within 48 hours following admission among patients with COVID-19 admitted in a tertiary care hospital in France, and to evaluate its association with initiation of dialysis, intensive care unit admission, and death.
Results: Among 200 patients with available data, urine protein-creatinine ratio at admission was ≥1 g/g for 84 (42%), although kidney function was normal in most patients, with a median serum creatinine of 0.94 mg/dl (interquartile range, 0.75-1.21). Median urine albumin-creatinine ratio was 110 mg/g (interquartile range, 50-410), with a urine albumin-protein ratio <50% in 92% of patients. Urine retinol binding protein concentrations, available for 85 patients, were ≥0.03 mg/mmol in 62% of patients. Urine protein-creatinine ratio ≥1 g/g was associated with initiation of dialysis (odds ratio, 4.87; 95% confidence interval, 2.03 to 13.0; P<0.001), admission to the intensive care unit (odds ratio, 3.55; 95% confidence interval, 1.93 to 6.71; P<0.001), and death (odds ratio, 3.56; 95% confidence interval, 1.90 to 6.54; P<0.001).
Conclusions: Proteinuria is very frequent among patients admitted for COVID-19 and may precede AKI. Low levels of albuminuria suggest a predominant tubular origin, confirmed by the elevated levels of urine retinol binding protein. Urine protein-creatinine ratio ≥1 g/g at admission is strongly associated with poor kidney and patient outcome.

Keywords: COVID-19; acute renal failure; prognosis; proteinuria; proximal tubule; tubular epithelium.
 
Back
Top Bottom